Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Original languageEnglish
JournalJournal of virus eradication
Volume5
Issue3
Pages (from-to)e1-e5
Number of pages5
ISSN2055-6640
Publication statusPublished - 2019

See relations at Aarhus University Citationformats

ID: 159849491